General Archive

-
News releasesTimur Avkiran awarded Industrial Fellowship
The Royal Commission for the Exhibition of 1851 has awarded Industrial Fellowships worth up to £80,000 to the UK’s 14…
-
News releasesSpringWorks Therapeutics launched to progress investigational therapies for patients with unmet medical needs
Four therapies could lead to new treatments for desmoid tumours, neurofibromatosis, hereditary xerocystosis and post-traumatic stress disorder.
-
News releasesLifeArc and AUTM forge international partnership to provide training for scholars in technology transfer
We have partnered with The Association of University Technology Managers (AUTM) Foundation to offer a competitive program that will provide…
-
News releasesLifeArc launches £100,000 awards – now closed
We have launched the LifeArc Translational Award for academic scientists to progress early stage drug discovery projects.
-
News releasesJuan Carlos Lopez to assist business development in North America
LifeArc has appointed Juan Carlos Lopez, founder of Haystack Science, to assist their business development activity in North America on…
-
News releasesPartnership with Metrion Biosciences to support LifeArc’s neuroscience small molecule drug discovery programme
Metrion to provide in-depth ion channel target class knowledge and assay support.
-
News releasesLifeArc becomes technology transfer partner to London School of Hygiene & Tropical Medicine
LifeArc has signed an agreement with the London School of Hygiene & Tropical Medicine to provide a range of technology…
-
News releasesLifeArc negotiates exclusive licence deal with Nemysis Limited for oral iron supplement technology
LifeArc has negotiated a licence for an oral iron supplement technology with Nemysis Limited (Nemysis). Iron oxo-hydroxide adipate tartrate (IHAT)…
-
News releasesLifeArc, Dstl and CDRD collaborate to identify antibacterial drug targets
LifeArc, The Centre for Drug Research and Development (CDRD), and the Defence Science and Technology Laboratory (Dstl) announced a collaboration…
-
News releasesLifeArc set to transform medical research landscape
Investing up to £500 million over the next five years to generate, fund and champion innovations in antimicrobials, neuroscience, personalised oncology…
-
News releasesMRC Technology and Biocartis initiate development of liquid biopsy test for breast cancer
Partnership aimed at the development of molecular diagnostic assays on Biocartis’ fully automated Idylla™ platform
-
News releasesApplying artificial intelligence in the search for new drugs
London, 11 April 2017 – BenevolentAI, a British artificial intelligence company, today announced that it has partnered with MRC Technology…
